Little Green Pharma (ASX:LGP) Total Liabilities: A$10.72 Mil (As of Mar. 2026)


What is Little Green Pharma Total Liabilities?

Little Green Pharma ASX:LGP -3.17% Total Liabilities is A$10.72 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Little Green Pharma's Total Liabilities for the quarter that ended in Mar. 2026 was A$10.72 Mil.

Little Green Pharma's quarterly Total Liabilities increased from Mar. 2025 (A$11.11 Mil) to Sep. 2025 (A$11.59 Mil) but then declined from Sep. 2025 (A$11.59 Mil) to Mar. 2026 (A$10.72 Mil).

Little Green Pharma's annual Total Liabilities increased from Mar. 2024 (A$10.21 Mil) to Mar. 2025 (A$11.11 Mil) but then declined from Mar. 2025 (A$11.11 Mil) to Mar. 2026 (A$10.72 Mil).

Little Green Pharma Total Liabilities Historical Data

* Premium members only.

The historical data trend for Little Green Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Little Green Pharma Total Liabilities Chart

Little Green Pharma Annual Data
Trend Jun19 Jun20 Jun21 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial 17.10 17.90 10.21 11.11 10.72

Little Green Pharma Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.21 10.47 11.11 11.59 10.72

Little Green Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Little Green Pharma's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7.036+(3.432+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.254+0)
=10.72

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=93.755-83.033
=10.72

Little Green Pharma's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7.036+(3.432+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.254+0)
=10.72

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=93.755-83.033
=10.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of A$10.72 Mil mean?
Little Green Pharma (ASX:LGP) has a Total Liabilities of A$10.72 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Little Green Pharma and its competitors.
Is Little Green Pharma's Total Liabilities too high?
Little Green Pharma's current Total Liabilities is A$10.72 Mil.
How does Little Green Pharma's Total Liabilities compare to ZTS and UTHR?
Little Green Pharma's Total Liabilities of A$10.72 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Little Green Pharma and its competitors. Little Green Pharma's current Total Liabilities is A$10.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.06 — trading 64.1% below its estimated fair value. The current Total Liabilities is A$10.72 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current Total Liabilities is A$10.72 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Little Green Pharma Business Description

Address 13A Bedbrook Place, Shenton Park, West Perth, Perth, WA, AUS, 6008
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).